Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    armaForce Inc., a privately held Columbus, Ohio based pharmaceutical R&D and manufacturing company, was founded in 1999. PharmaForce began as a small team R&D outfit, but quickly expanded to include manufacturing capabilities. In 2009, Luitpold Pharmaceuticals, Inc., a New York based U.S. Company of Daiichi-Sankyo Co., Ltd. (Corporate Headquarters: Tokyo, Japan), acquired PharmaForce. This acquisition allowed for the expansio...
    armaForce Inc., a privately held Columbus, Ohio based pharmaceutical R&D and manufacturing company, was founded in 1999. PharmaForce began as a small team R&D outfit, but quickly expanded to include manufacturing capabilities. In 2009, Luitpold Pharmaceuticals, Inc., a New York based U.S. Company of Daiichi-Sankyo Co., Ltd. (Corporate Headquarters: Tokyo, Japan), acquired PharmaForce. This acquisition allowed for the expansion of the R&D pipeline, increased manufacturing capacity, and an ability to develop a robust pipeline in the fast growing generic injectable market.

    List your booth number for exhibitions, ask us